Overgrowth syndromes

Current Opinion in Pediatrics

Volumn 24, Issue 4, 2012, Pages 505-511

  Neylon, Orla M ^a   Werther, George A ^a   Sabin, Matthew A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

imprinting; overgrowth; syndromes; tall stature

Indexed keywords

ESTROGEN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

BECKWITH WIEDEMANN SYNDROME; CONGENITAL TUMOR; DISEASE CLASSIFICATION; ESTROGEN DEFICIENCY; GENETIC ASSOCIATION; GENETIC DISORDER; GROWTH DISORDER; HUMAN; KLINEFELTER SYNDROME; NEWBORN PERIOD; OVERGROWTH SYNDROME; PALLISTER KILLIAN SYNDROME; PERLMAN SYNDROME; PRIORITY JOURNAL; REVIEW; SIMPSON GOLABI BEHMEL SYNDROME; SOTOS SYNDROME; TALL STATURE; WEAVER SYNDROME;

ABNORMALITIES, MULTIPLE; ADOLESCENT; CHILD; CHILD, PRESCHOOL; CONGENITAL HYPOTHYROIDISM; CRANIOFACIAL ABNORMALITIES; FEMALE; FETAL MACROSOMIA; GROWTH DISORDERS; HAND DEFORMITIES, CONGENITAL; HUMANS; INFANT; MALE; MUTATION; PHENOTYPE; PROGNOSIS; PROTEUS SYNDROME; WILMS TUMOR;

EID: 84863816903     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0b013e3283558995     Document Type: Review

References (50)

1. Domingo-Sananes MR, Kapuy O, Hunt T, Novak B. Switches and latches: a biochemical tug-of-war between the kinases and phosphatases that control mitosis. Philos Trans R Soc Lond B Biol Sci 2011; 366:3584-3594.
2. Spath S-S, Andrade AC, Chau M, Nilsson O. Local regulation of growth plate cartilage. Endocr Dev 2011; 21:12-22.
3. Hietakangas V, Cohen SM. Regulation of tissue growth through nutrient sensing. Annu Rev Genet 2009; 43:389-410.
4. Barbieri M, Bonafe M, Franceschi C, Paolisso G. Insulin/IGF-I-signaling pathway: an evolutionarily conserved mechanism of longevity from yeast to humans. Am J Physiol Endocrinol Metab 2003; 285:E1064-E1071.
5. Ohlsson C, Mohan S, Sjogren K, et al. The role of liver-derived insulin-like growth factor-I. Endocr Rev 2009; 30:494-535.
6. Rikken B, van Doorn J, Ringeling A, et al. Plasma levels of insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein-3 in the evaluation of childhood growth hormone deficiency. Horm Res 1998; 50:166-176.
7. Nilsson O, Marino R, De Luca F, et al. Endocrine regulation of the growth plate. Horm Res 2005; 64:157-165.
8. Chagin AS, Savendahl L. Estrogens and growth: review. Pediatr Endocrinol Rev 2007; 4:329-334.
9. Greulich W, Pyle S. Radiographic atlas of skeletal development of the hand and wrist. Stanford, California: Stanford University Press; 1950.
10. Bayley N, Pinneau SR. Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards. J Pediatr 1952; 40:423.
11. Weksberg R, Shuman C, Beckwith JB. Beckwith-Wiedemann syndrome. Eur J Hum Genet 2010; 18:8-14.
12. Judge TA, Cable DM. The effect of physical height on workplace success and income: preliminary test of a theoretical model. J Appl Psychol 2004; 89:428-441.
13. Bilezikian JP, Morishima A, Bell J, Grumbach MM. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. N Engl J Med 1998; 339:599-603.
14. Carani C, Qin K, Simoni M, et al. Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med 1997; 337:91-95.
15. Visser R, Kant SG, Wit JM, Breuning MH. Overgrowth syndromes: from classical to new. Pediatr Endocrinol Rev 2009; 6:375-394.
16. Mart?́n-Subero JI. How epigenomics brings phenotype into being. Pediatr Endocrinol Rev 2011; 9:506.
17. Choufani S, Shuman C, Weksberg R. Beckwith-Wiedemann syndrome. Am J Med Genet C Semin Med Genet 2010; 154C:343-354.
18. DeBaun MR, Tucker MA. Risk of cancer during the first four years of life in children from the Beckwith-Wiedemann Syndrome Registry. J Pediatr 1998; 132 (3 Pt 1):398-400.
19. de Boer L, Kant SG, Karperien M, et al. Genotype-phenotype correlation in patients suspected of having Sotos syndrome. Horm Res 2004; 62:197-207.
20. de Boer L, Hoogerbrugge CM, van Doorn J, et al. Plasma insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), acid-labile subunit (ALS) and IGFBP-3 proteolysis in individuals with clinical characteristics of Sotos syndrome. J Pediatr Endocrinol 2004; 17:615-627.
21. Gracia Bouthelier R, Lapunzina P. Follow-up and risk of tumors in overgrowth syndromes. J Pediatr Endocrinol 2005; 18 (Suppl 1):1227-1235.
22. Tatton-Brown K, Rahman N. Sotos syndrome. Eur J Hum Genet 2007; 15:264-271.
23. Rio M, Clech L, Amiel J, et al. Spectrum of NSD1 mutations in Sotos and Weaver syndromes. J Med Genet 2003; 40:436-440.
24. Douglas J, Hanks S, Temple IK, et al. NSD1 mutations are the major cause of Sotos syndrome and occur in some cases of Weaver syndrome but are rare in other overgrowth phenotypes. Am J Hum Genet 2003; 72:132-143.
25. Gibson WT, Hood RL, Zhan SH, et al. Mutations in EZH2 cause Weaver syndrome. Am J Hum Genet 2012; 90:110-118.
26. Tatton-Brown K, Hanks S, Ruark E, et al. Germline mutations in the oncogene EZH2 cause Weaver syndrome and increased human height. Oncotarget 2011; 2:1127-1133.
27. Neri G, Moscarda M. Overgrowth syndromes: a classification. Endocr Dev 2009; 14:53-60.
28. Scott RH, Walker L, Olsen OE, et al. Surveillance for Wilms tumour in at-risk children: pragmatic recommendations for best practice. Arch Dis Child 2006; 91:995-999.
29. Garganta CL, Bodurtha JN. Report of another family with Simpson-Golabi-Behmel syndrome and a review of the literature. Am J Med Genet 1992; 44:129-135.
30. Alessandri J-L, Cuillier F, Ramful D, et al. Perlman syndrome: report, prenatal findings and review. Am J Med Genet A 2008; 146A:2532-2537.
31. Astuti D, Morris MR, Cooper WN, et al. Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumour susceptibility. Nat Genet 2012; 44:277-284.
32. Struthers JL, Cuthbert CD, Khalifa MM. Parental origin of the isochromosome 12p in Pallister-Killian syndrome: molecular analysis of one patient and review of the reported cases. Am J Med Genet 1999; 84: 111-115.
33. Theisen A, Rosenfeld JA, Farrell SA, et al. aCGH detects partial tetrasomy of 12p in blood from Pallister-Killian syndrome cases without invasive skin biopsy. Am J Med Genet A 2009; 149A:914-918.
34. Abramsky L, Chapple J. 47,XXY (Klinefelter syndrome) and 47,XYY: estimated rates of and indication for postnatal diagnosis with implications for prenatal counselling. Prenat Diagn 1997; 17:363-368.
35. Herlihy AS, Halliday JL, Cock ML, McLachlan RI. The prevalence and diagnosis rates of Klinefelter syndrome: an Australian comparison. Med J Aust 2011; 194:24-28.
36. Lanfranco F, Kamischke A, Zitzmann M, Nieschlag E. Klinefelter's syndrome. Lancet 2004; 364:273-283.
37. Jacobs PA, Hassold TJ, Whittington E, et al. Klinefelter's syndrome: an analysis of the origin of the additional sex chromosome using molecular probes. Ann Hum Genet 1988; 52 (Pt 2):93-109.
38. Ogata T, Matsuo N, Nishimura G. SHOX haploinsufficiency and overdosage: impact of gonadal function status. J Med Genet 2001; 38:1-6.
39. . Wikstrom AM, Painter JN, Raivio T, et al. Genetic features of the X chromosome affect pubertal development and testicular degeneration in adolescent boys with Klinefelter syndrome. Clin Endocrinol (Oxf) 2006; 65: 92-97.
40. Houk CP, Rogol A, Lee PA. Fertility in men with Klinefelter syndrome. Pediatr Endocrinol Rev 2010; 8 (Suppl 1):182-186.
41. De Sanctis V, Ciccone S. Fertility preservation in adolescents with Klinefelter's syndrome. Pediatr Endocrinol Rev 2010; 8 (Suppl 1):178-181.
42. Schiff JD, Palermo GD, Veeck LL, et al. Success of testicular sperm extraction (corrected) and intracytoplasmic sperm injection in men with Klinefelter syndrome [Erratum appears in J Clin Endocrinol Metab 2006; 91:4027]. J Clin Endocrinol Metab 2005; 90:6263-6267.
43. Chu EC, Tarnawski AS. PTEN regulatory functions in tumor suppression and cell biology. Med Sci Monit 2004; 10:RA235-RA241.
44. Spiegel M, Oexle K, Horn D, et al. Childhood overgrowth in patients with common NF1 microdeletions. Eur J Hum Genet 2005; 13:883-888.
45. Giunta C, Randolph A, Al-Gazali LI, et al. Nevo syndrome is allelic to the kyphoscoliotic type of the Ehlers-Danlos syndrome (EDS VIA). Am J Med Genet A 2005; 133A:158-164.
46. Thomason JL, Abramowsky CR, et al. Proteus syndrome: three case reports with a review of the literature. Fetal Pediatr Pathol 2012; 31:145.
47. Lindhurst MJ, Sapp JC, Teer JK, et al. A mosaic activating mutation in AKT1 associated with the Proteus syndrome. N Engl J Med 2011; 365:611-619.
48. Melis D, Genesio R, Del Giudice E, et al. Selective cognitive impairment and tall stature due to chromosome 19 supernumerary ring. Clin Dysmorphol 2012; 21:27-32.
49. DeBaun MR, Niemitz EL, Feinberg AP. Association of in vitro fertilization with Beckwith-Wiedemann syndrome and epigenetic alterations of LIT1 and H19. Am J Hum Genet 2003; 72:156-160.
50. Miles HL, Hofman PL, Peek J, et al. In vitro fertilization improves childhood growth and metabolism. J Clin Endocrinol Metab 2007; 92:3441-3445.